Pretreatment with a 55-kDa tumor necrosis factor receptor- immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 296-299

  Van Der Poll, Tom ^b   Jansen, Patty M ^b   Van Zee, Kimberly J ^b   Hack, C Erik ^b   Oldenburg, Hester A ^b   Loetscher, Hansruedi ^b   Lesslauer, Werner ^b   Lowry, Stephen F ^b   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; ELASTASE; HYBRID PROTEIN; IMMUNOGLOBULIN G; PHOSPHOLIPASE A2; PLACEBO; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RO 45 208; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BACTEREMIA; BASOPHIL DEGRANULATION; BLOOD CLOTTING; CONTROLLED STUDY; ESCHERICHIA COLI; FIBRINOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; LETHALITY; NEUTROPHIL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0030917689     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514034     Document Type: Article

References (15)

1. Van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995;3:1-12.
2. Levi M, ten Cate H, van der Poll T, van Deventer SJH. New insights in the pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993;270:975-9.
3. Van der Poll T, Büller HR, Ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7.
4. Van der Poll T, Jansen PM, van Zee KJ, et al. Tumor necrosis factor α induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor. Blood 1996;88:922-7.
5. Hinshaw LB, Tekamp-Olson P, Chang ACK, et al. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNFα). Circ Shock 1990;30:279-92.
6. Hinshaw LB, Emerson TE, Taylor FB Jr, et al. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma 1992;33:568-73.
7. Stevens DL, Bryant AE, Hackett SP, et al. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis 1996;173:619-26.
8. Van der Poll T, Levi M, Van Deventer SJH, et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994;83:446-51.
9. Van Zee KJ, Moldawer LL, Oldenburg HSA, et al. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J Immunol 1996;156:2221-30.
10. 2 in sepsis. Studies in non-human primates following interleukin-1α administration and during lethal bacteremia. Blood 1995;86:1027-34.
11. Evans TJ, Moyes D, Carpenter A, et al. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of Gram-negative sepsis. J Exp Med 1994;180:2173-9.
12. Biemond BJ, Levi M, ten Cate H, et al. Plasminogen activator and PAI-1 release during experimental endotoxemia in chimpanzees: effects of various interventions in the cytokine and coagulation cascades. Clin Sci 1995:88:587-94.
13. 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators of fatal sepsis. J Lab Clin Med 1992;19:159-68.
14. Van der Poll T, van Deventer SJH, Hack CE, et al. Effects on leukocytes following injection of tumor necrosis factor into healthy humans. Blood 1992;79:693-8.
15. Redl H, Schlag G, Schiesser A, Davies J. Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons. Am J Physiol 1993;264:H2119-23.